Dalbavancin: all 23 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk LeukemiaRecruitingNCT06810583Phase 1
- Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic AnalysisRecruitingNCT06266494Phase 4
- DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus BacteremiaCompletedNCT04775953Phase 2Results posted
- Hospital Avoidance Strategies for ABSSSITerminatedNCT03372941Phase 4Results posted
- Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT03233438Phase 4Results posted
- Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective EndocarditisTerminatedNCT03148756Phase 2Results posted
- Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With OsteomyelitisTerminatedNCT03091439Phase 2Results posted
- Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT02961764Phase 4Results posted
- Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSACompletedNCT02814916Phase 3Results posted
- Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With OsteomyelitisCompletedNCT02685033Phase 2Results posted
- Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT02127970Phase 3Results posted
- Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01431339Phase 3Results posted
- Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01339091Phase 3Results posted
- Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee ReplacementsActive, not recruitingNCT05046860Not applicable
- Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient TransitionTerminatedNCT04847921Phase 2/3
- Dalbavancin Outpatient PilotWithdrawnNCT03982030Phase 4
- Dalbavancin For The Treatment of Gram Positive Osteoarticular InfectionsCompletedNCT03426761Phase 4
- Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial InfectionTerminatedNCT02688790Phase 1
- Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous OsteomyelitisWithdrawnNCT02344511Phase 3
- A P3 Comparator Trial in Community Acquired Bacterial PneumoniaWithdrawnNCT02269644Phase 3
- A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.CompletedNCT01946568Phase 1
- Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial InfectionsCompletedNCT00678106Phase 1
- Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream InfectionsStatus unknownNCT00057369Phase 2